EU Health Emergency Response Authority Calls On Off-Patent Sector
HERA: ‘We Need To Build More In Europe,’ ‘Too Dependent On Others’
Executive Summary
The director-general of the European Commission’s recently-formed Health Emergency Response Authority addressed delegates to off-patent association Medicines for Europe’s 2022 annual conference, noting that it was preparing a report for post-summer as the HERA assessed its priorities.
You may also be interested in...
Generics Bulletin Editor’s Picks For Q2 2022
Looking back over the second quarter of 2022, Generics Bulletin executive editor Dave Wallace picks out highlights from April to June that include multiple first generic and biosimilar launches, some noteworthy executive moves, further preparation for biosimilar competition to Humira in the US, and a major European industry conference.
EU’s AMR Transferable Exclusivity Voucher Plan 'Not Fit For Purpose'
A European public health NGO has disputed the suggestion that a transferable exclusivity extension is the answer to the lack of innovative antimicrobial drugs in company pipelines.
Coronavirus Notebook: Australia To Assess Omicron-Adapted Vaccine Riltozinameran, EU Advises On Boosters For Older & Vulnerable People
The EMA has drawn up a list of groups of critical medicines for use in health emergencies, while the European Parliament’s special COVID-19 committee is to discuss vaccination campaigns and challenges with the chiefs of the ECDC and HERA.